Evolus
EOLS
115 hedge funds and large institutions have $205M invested in Evolus in 2021 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 24 reducing their positions, and 9 closing their positions.
211% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 9
140% more call options, than puts
Call options by funds: $11.3M | Put options by funds: $4.74M
100% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 24
84% more capital invested
Capital invested by funds: $112M → $205M (+$93.6M)
20% more funds holding
Funds holding: 96 → 115 (+19)
10.31% more ownership
Funds ownership: 19.69% → 30% (+10%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
+$15.2M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.38M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.02M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$5.79M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$5.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$4.48M |
| 2 |
Millennium Management
New York
|
-$1.98M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
-$1.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.03M |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$333K |
EOLS Hedge Fund Activity: Q2 2021 in Review
115 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q2 2021, worth a combined $205M — up 84% from $112M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new EOLS positions and 9 closed out — a net gain of 19 holders — while 48 added to existing stakes and 24 trimmed.
The largest buyer was First Manhattan, opening a new position worth an estimated $15.2M. The largest seller was Invesco, cutting an estimated $4.48M.
- 115 institutional investors held Evolus (EOLS) as of Q2 2021, up from 96 in Q1 2021.
- Funds reported $205M of Evolus stock for Q2 2021, up 84% quarter-over-quarter.
- 28 funds opened new Evolus positions in Q2 2021 and 9 closed out, a net change of +19 holders.
- The largest Evolus buyer in Q2 2021 was First Manhattan, an estimated $15.2M added.
- The largest Evolus seller in Q2 2021 was Invesco, an estimated $4.48M sold.
Based on aggregated 13F filings for Q2 2021.